Achieve Life Sciences to Participate in Upcoming Investor Conferences in London and New York
Achieve Life Sciences announced CEO participation in two investor conferences regarding cytisinicline's development for nicotine dependence treatment.Quiver AI SummaryAchieve Life Sciences, Inc., a late-stage...
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022
SEATTLE and VANCOUVER, British Columbia, July 28, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical...
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
SEATTLE and VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference
SEATTLE and VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical...